IMIDomics, Inc.
↗San Rafael, USA
IMIDomics is a biotechnology company focused on the discovery and development of first-in-class medicines for immune-mediated inflammatory diseases (IMIDs). The company utilizes its proprietary 'Clinical Discovery Engine™', which integrates longitudinal clinical, epidemiological, and multi-omic biomolecular data from a large, dedicated patient biobank to identify novel therapeutic targets and stratify patient populations for precision medicine.
Founded in 2015 as a spin-off from the Vall d'Hebron Institute of Research in Barcelona, Spain, the company maintains a strong research presence in Spain while being headquartered in San Rafael, California. IMIDomics collaborates with academic institutions and pharmaceutical partners to accelerate the development of targeted therapies for conditions such as lupus, Crohn's disease, rheumatoid arthritis, and ulcerative colitis.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Immunology/Autoimmune Biotech
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$5M
Founded:2015
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$16.5M
Investors:DNS Capital, Bristol Myers Squibb, The Pritzker Organization, Tao Capital, Evotec SE, UCB S.A.
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Monoclonal antibody, Bispecific antibody, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Bristol Myers Squibb (Research collaboration), University of Barcelona (License and collaboration), Twist Bioscience (Antibody discovery), Formation Bio (Licensing of anti-CD226 program)
COMPETITION
Position:Emerging
Competitors:ADMA Biologics, BioNTech, Abcellera Biologics
LEADERSHIP
Key Executives:
Fred Craves - Chairman and CEO
Sara Marsal - Founder and Chief Medical Officer
Manuel López-Figueroa - Chief Operating Officer
Scientific Founders:Sara Marsal, Richard M. Myers
LINKS
Website:imidomics.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of IMIDomics, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with IMIDomics, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.